BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29286926)

  • 1. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
    Hogue AN; Temple-Cooper ME; Lagzdins M; Worley S; Scwersenski J; Floyd R; Saker F
    J Neonatal Perinatal Med; 2017; 10(4):371-380. PubMed ID: 29286926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Delivery Room Resuscitation of Neonates Exposed to Selective Serotonin Reuptake Inhibitors.
    Ulbrich KA; Zumpf K; Ciolino JD; Shah M; Miller ES; Wisner KL
    J Pediatr; 2021 May; 232():103-108.e2. PubMed ID: 33453205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
    Marks C; Silvola R; Teal E; Quinney SK; Haas DM
    Pharmacotherapy; 2021 Nov; 41(11):907-914. PubMed ID: 34587291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N; Pedersen LH; Henriksen TB
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
    Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
    Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
    Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF
    Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study.
    Cornet MC; Wu YW; Forquer H; Avalos LA; Sriram A; Scheffler AW; Newman TB; Kuzniewicz MW
    Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):294-300. PubMed ID: 38071585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
    JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In utero antidepressant exposure and neurodevelopment in preterm infants.
    Batton B; Batton E; Weigler K; Aylward G; Batton D
    Am J Perinatol; 2013 Apr; 30(4):297-301. PubMed ID: 22893558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 18. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
    Ansah DA; Reinking BE; Colaizy TT; Roghair RD; Haskell SE
    Neonatology; 2019; 115(4):320-327. PubMed ID: 30836356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Handley AP; Williams M
    J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.